Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
News

US estrogen plus progestin HRT trial stopped due to increased risk of breast cancer, stroke and heart attack

Barbara Sibbald
CMAJ August 06, 2002 167 (3) 294-294-a;
Barbara Sibbald
CMAJ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Article Information

vol. 167 no. 3 294-294-a
PubMed 
12186184
History 
  • Published online August 6, 2002.
Copyright & Usage 
© 2002

Author Information

  1. Barbara Sibbald
  1. CMAJ

Statistics from Altmetric.com

Usage statistics: March 2003 to March 2023

AbstractFullPdf
Mar 200301213
Apr 20030199
May 20030111
Jun 20030181
Jul 20030181
Aug 20030143
Sep 20030186
Oct 20030201
Nov 20030180
Dec 20030221
Jan 20040101
Feb 20040232
Mar 20040424
Apr 20040331
May 20040502
Jun 20040482
Jul 20040507
Aug 20040514
Sep 20040260
Oct 20040363
Nov 20040120
Dec 2004080
Jan 20050123
Feb 20050191
Mar 20050131
Apr 2005081
May 2005060
Jun 2005042
Jul 2005031
Aug 20050118
Sep 2005062
Oct 20050134
Nov 20050133
Dec 2005040
Jan 2009020
Feb 2009030
Mar 2009020
Apr 2009020
May 2009021
Jun 2009020
Jul 2009040
Aug 2009042
Sep 2009041
Oct 2009031
Nov 2009060
Dec 2009021
Jan 2010071
Feb 2010010
Mar 2010020
May 2010001
Jul 2010001
Aug 2010010
Oct 2010051
Nov 2010031
Dec 2010021
Jan 2011021
Feb 2011042
Mar 2011021
Apr 2011021
May 2011055
Jun 2011083
Jul 2011010
Aug 2011034
Sep 2011040
Oct 2011042
Nov 2011040
Dec 2011031
Jan 2012056
Feb 20120136
Mar 2012033
Apr 2012077
May 20120102
Jun 20120128
Jul 2012063
Aug 2012045
Sep 2012064
Oct 2012047
Nov 2012038
Dec 20120133
Jan 2013071
Feb 2013064
Mar 2013051
Apr 2013053
May 2013064
Jun 2013016
Jul 2013031
Aug 2013023
Sep 2013012
Oct 2013035
Nov 2013020
Dec 2013010
Jan 2014022
Apr 2014011
May 2014031
Jun 2014001
Jul 2014023
Aug 2014051
Sep 20140100
Oct 2014063
Nov 2014073
Dec 2014003
Jan 2015041
Feb 2015050
Mar 2015054
Apr 2015050
May 2015051
Jun 2015041
Jul 2015031
Aug 2015040
Sep 2015020
Oct 2015050
Nov 20150111
Dec 2015081
Jan 2016063
Feb 2016041
Mar 2016003
Apr 2016032
May 2016050
Jun 2016040
Jul 2016020
Aug 2016013
Sep 2016014
Oct 2016047
Nov 2016051
Dec 2016022
Jan 2017020
Feb 2017010
Apr 2017020
May 2017010
Jun 2017001
Jul 2017020
Aug 2017011
Sep 2017010
Oct 2017023
Nov 2017031
Dec 20170243
Jan 2018040
Feb 2018072
Mar 2018090
Apr 2018020
May 2018030
Jun 2018050
Jul 2018011
Aug 2018016
Sep 2018005
Oct 2018020
Nov 2018061
Dec 2018040
Jan 2019011
Feb 2019021
Mar 2019022
Apr 2019010
May 2019031
Jun 2019010
Jul 2019010
Aug 2019011
Sep 2019020
Oct 2019021
Nov 2019012
Jan 2020010
Feb 2020022
Mar 2020010
Apr 2020010
May 2020011
Jun 2020010
Jul 2020040
Sep 2020013
Oct 2020003
Nov 2020021
Dec 2020012
Jan 2021022
Mar 2021011
May 2021031
Jun 2021031
Jul 2021012
Oct 2021030
Nov 2021022
Dec 2021002
Jan 2022010
Feb 2022002
Mar 2022031
Apr 2022003
May 2022020
Jun 2022041
Jul 2022047
Aug 2022063
Sep 2022035
Oct 2022064
Nov 20220716
Dec 2022042
Jan 2023062
Feb 2023023
Mar 2023011
PreviousNext
Back to top

In this issue

CMAJ
Vol. 167, Issue 3
6 Aug 2002
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
US estrogen plus progestin HRT trial stopped due to increased risk of breast cancer, stroke and heart attack
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
US estrogen plus progestin HRT trial stopped due to increased risk of breast cancer, stroke and heart attack
Barbara Sibbald
CMAJ Aug 2002, 167 (3) 294-294-a;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
US estrogen plus progestin HRT trial stopped due to increased risk of breast cancer, stroke and heart attack
Barbara Sibbald
CMAJ Aug 2002, 167 (3) 294-294-a;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Resignations at Canada’s drug pricing panel raise independence questions
  • Provinces accept federal health funding deal
  • Feds propose $196B health funding deal with few strings attached
Show more News

Similar Articles

Collections

  • Topics
    • Pharmacology & toxicology
    • Reproductive health, infertility & pregnancy

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire